Income Statement | | | | | | | | | | | |
| | | | | | | Original | | | | |
EUR | | | Latest | | Year-to-date Ending | |
(in millions) | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Jun-24 | | Jun-23 | Jun-24 | |
| FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM | | YTD-1 | YTD | |
| | | | | | | | | | | |
Net Revenue | 17 | 17 | 20 | 26 | 24 | | 29 | | 10 | 15 | |
% Growth | NA | -1.0% | 19.7% | 25.8% | -6.3% | | | | | 48.5% | |
| | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
General and Admin | (0) | (1) | (0) | (1) | (1) | | (1) | | (1) | (1) | |
Other Exp / (Inc) | 26 | (5) | (40) | (14) | 3 | | (17) | | 2 | (19) | |
Total Operating Exp | 26 | (5) | (40) | (15) | 3 | | (18) | | 1 | (20) | |
| | | | | | | | | | | |
Operating Income | 43 | 12 | (20) | 11 | 27 | | 11 | | 11 | (4) | |
% Revenue | 250.4% | 69.7% | -97.1% | 42.7% | 110.5% | | 37.3% | | 110.6% | -27.7% | |
| | | | | | | | | | | |
Interest Expense | (2) | (0) | (1) | (0) | 2 | | 2 | | 0 | 1 | |
Pre-tax Income | 41 | 11 | (21) | 11 | 28 | | 13 | | 12 | (3) | |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Provision for Taxes | (4) | (2) | 1 | (2) | (3) | | (2) | | (1) | (0) | |
Net Income to Company | 37 | 10 | (20) | 9 | 25 | | 11 | | 10 | (4) | |
% Margin | 216.3% | 56.2% | -98.5% | 34.3% | 102.8% | | 36.5% | | 101.0% | -23.6% | |
| | | | | | | | | | | |
Minority Interest in Earnings | | | | | | | 0 | | 0 | 0 | |
Net Income to Stockholders | 37 | 10 | (20) | 9 | 25 | | 11 | | 10 | (4) | |
| | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Other Adj. | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
| | | | | | | | | | | |
Net Income to Common | 37 | 10 | (20) | 9 | 25 | | 11 | | 10 | (4) | |
% Margin | 216.3% | 56.2% | -98.5% | 34.3% | 102.8% | | 36.5% | | 101.0% | -23.6% | |
| | | | | | | | | | | |
As Reported | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.25 | 0.06 | (0.14) | 0.06 | 0.17 | | 0.08 | | 0.07 | (0.02) | |
Diluted EPS (Continuing Ops) | 0.25 | 0.06 | (0.14) | 0.06 | 0.17 | | 0.08 | | 0.07 | (0.02) | |
| | | | | | | | | | | |
WA Basic Shares Out. | 148 | 148 | 148 | 148 | 148 | | 208 | | 148 | 208 | |
WA Diluted Shares Out. | 148 | 148 | 148 | 148 | 148 | | 208 | | 148 | 208 | |
| | | | | | | | | | | |
Unusual Items Reconciliation | | | | | | | | | | | |
Addback: Other Non Operating Expenses, Total | (0) | 1 | 0 | 0 | 0 | | 0 | | 0 | (0) | |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | | (0) | | 0 | (0) | |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Addback: Asset Writedown | (35) | (5) | 28 | (3) | (18) | | (2) | | (7) | 9 | |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | | 0 | | 0 | 0 | |
Total Unusual Items | (35) | (4) | 28 | (3) | (18) | | (2) | | (7) | 9 | |
% Margin | -204.3% | -21.9% | 137.0% | -10.7% | -73.8% | | -6.3% | | -70.6% | 55.9% | |
| | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | |
Net Income to Company | 37 | 10 | (20) | 9 | 25 | | 11 | | 10 | (4) | |
Addback: Unusual Items | (35) | (5) | 28 | (3) | (18) | | (2) | | (7) | 9 | |
Less: Tax Benefit of Unusual Items (26%) | 9 | 1 | (7) | 1 | 5 | | 1 | | 2 | (2) | |
Adjusted Net Income | 11 | 6 | 1 | 7 | 11 | | 9 | | 5 | 3 | |
% Margin | 66.9% | 36.1% | 2.9% | 26.0% | 46.9% | | 30.8% | | 48.8% | 17.8% | |
| | | | | | | | | | | |
Adjusted Basic EPS | 0.08 | 0.04 | 0.00 | 0.05 | 0.08 | | 0.04 | | 0.03 | 0.01 | |